Sodium Status in Septic Patients and Its Relation to Prognosis an Hospital Stay
NCT ID: NCT04564508
Last Updated: 2021-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2021-01-01
2021-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Observational Study of Sepsis
NCT05309889
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109
N\L Ratio Versus L\A Ratio as a Predictor of Morbidity and Mortality in Sepsis and Septic Shock
NCT05825118
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400
Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
NCT01841190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Acute hypernatremia is considered one of the features of homeostasis disturbances, which is common in septic patients with an incidence reaching up to 47% Finding biomarkers which predict the outcome of sepsis is challenging . Since electrolyte imbalance, specifically hypernatremia, is one of the commonest problems associated with sepsis and septic shock patients \[20, 21\]. It is, therefore, of current interest to study the evolution of sepsis in patients who have been shown to have hypernatremia.
Recent evidence shows that serum sodium levels may not be completely explained by fluid balance or sodium intake . Some studies suggest that sodium is intimately tied to the immune system, thus raising the question of whether inflammatory states such as sepsis can play a role in the development of hypernatremia
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Sepsis : 2 or more of the SIRS criteria :
* Temperature \>38 or \<36 c
* Heart Rate \>90 beats/minute
* Respiratory rate \>20 cycle /minute
* wbc \>20,000 or \< 4,000 Plus the presumed existence of infection
* Blood pressure can be normal Septic shock : the same as sepsis plus refractory hypotension
* After bolus of 20- 40 ml/kg patient has one of the following :
* SBP \>90 mm Hg
* MAP \<65 mm Hg
* Decrease of 40 mm Hg of base line hypernatremia \[Na+\]\> 145 mmol/L eunatremia \[135-145\]mmol/l hyponatremia \<135 mmol/L
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kareem Sherif
Principal investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ahmed Mohamed Obeid Allah, Assistant professor
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sodium level in septic patient
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.